AzTrials
AzTrials

Malaria, FalciparumPhase 4NCT01713517

Impact of Insecticide Resistance on Vector Control

A Phase 4 study testing Indoor residual insecticide spraying (IRS) and Long Lasting Insecticidal Nets (LLIN) in people with Malaria, Falciparum, run by London School of Hygiene and Tropical Medicine at 3 sites in Sudan.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of the study is to determine whether long lasting insecticidal nets and indoor residual insecticide spraying, alone or in combination, are effective for controlling insecticide resistant anopheles mosquitoes for malaria prevention. Read more about this study

Who is it for?
Ages 6 months to 10 yearsHealthy volunteers can take part
Conditions the study is for
Malaria, Falciparum
What is being tested?
Indoor residual insecticide spraying (IRS) and Long Lasting Insecticidal Nets (LLIN)
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
28,000 participants
Where
3 sitesSudan
Study dates
Apr 2011to Oct 2014
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 6 months to 10 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Children older than 6 months and younger than 10 years in approximately 100 randomly selected households in all 140 study clusters selected in the four study areas

Who cannot join

  • Children living in households within 1 km from the edge of a neighbouring cluster (the buffer zone)

Trial locations and contacts

3 sites in 1 country.

Hmooda T Kafy, MSc (London) contact

+249 123 399 994

hmoodak@yahoo.com

Bashir A Ismail, MSc (USM) contact

+249 912938842

bashiradam69@yahoo.co.uk

Sudan3 sites, 3 recruiting
  • Malaria Control Programme

    Gedarif, Gedarif State

    Anwar Banaga, MSc, +249 122645846, anwrbanaga@yahoo.com

    Recruiting
  • Malaria Control Programme

    Kassala, Kassala

    Shaaaldeen H Hussein, MSc, +249 117587536, shaaaldeen64@gmail.com

    Recruiting
  • Malaria Control Programme

    Wad Medani, Al Jazirah

    Sakhr B Elshiekh, MSc, +249 117587549, sakhr_14@yahoo.com

    Recruiting

Other trials in Sudan

About this study

Official title: Impact of Insecticide Resistance in Anopheles Arabiensis on the Effectiveness of Malaria Vector Control in Sudan

The purpose of the study is to determine whether long lasting insecticidal nets and indoor residual insecticide spraying, alone or in combination, are effective for controlling insecticide resistant anopheles mosquitoes for malaria prevention.

Read the detailed description

The study will assess the impact that insecticide resistance has on the effectiveness of malaria vector control tools LLIN and IRS. This is done by a cluster randomised trials of universal coverage LLINs versus universal coverage LLINs in combination with IRS, with levels of baseline insecticide resistance in the main vector balanced between the two study arms. In each cluster resistance to the insecticide used on LLINs is monitored, and malaria incidence is estimated from cluster specific cohorts of children followed up over the duration of the study. Resistance impact will be assessed from the ratio of incidence rates in clusters with high compared to those with low resistance and from a continuous measure of resistance expressed as percentage loss of mosquito mortality when exposed to insecticide in standardised WHO tests. Resistance mechanisms will be studied in subsets of study clusters.

Being tested
Indoor residual insecticide spraying (IRS), Long Lasting Insecticidal Nets (LLIN)
Keywords
Mosquito Control, Insecticide Resistance
Medical subject headings
Malaria, Falciparum

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Indoor residual insecticide spraying (IRS)Other

    Also called IRS, Pesticide, Bendiocarb, Deltamethrin

    Application of insecticide to interior walls of domiciliary structures to kill malaria vector mosquitoes which rest on walls after taking human blood meal

  • Long Lasting Insecticidal Nets (LLIN)Device

    Also called Insecticide Treated Nets (ITN), Permanet2.0

    Provision of LLIN to all community members in the clusters allocated to the study arm. LLIN protect individuals from bites by malaria vector mosquitoes by providing a physical barrier and insecticidal and repellent effect.

Study groups in NCT01713517
Study groupRoleWhat they receive
Universal coverage of Long Lasting Insecticidal Nets (LLIN)Active comparatorDistribution of long lasting insecticidal nets to all community members in the study arm allowing for at least one net per 2 persons
Receives: Device: Long Lasting Insecticidal Nets (LLIN)
LLIN Plus Indoor Residual SprayingExperimentalDistribution of long lasting insecticidal nets to all community members in the study arm allowing for at least one net per 2 persons plus indoor residual spraying with insecticide of interior walls of all houses twice yearly.
Receives: Other: Indoor residual insecticide spraying (IRS); Device: Long Lasting Insecticidal Nets (LLIN)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Malaria Incidence

    Infection with malarial parasites determined by rapid diagnostic tests/microscopy in cohort members who report or have fever (>37.5C)

    Measured: 3 years

Secondary outcomes (3)
  1. Prevalence of P.falciparum Infection

    Infection with plasmodial parasites (falciparum and/or vivax) in randomly selected members of the study cohort in each study cluster during the peak of the malaria transmission season by rapid diagnostic test

    Measured: 3 years

  2. Entomological Innoculation rate

    Anopheles arabiensis mosquitoes collected in sentinel clusters by light trap, window trap, clay pot and pyrethrum sheet collection and determination of sporozoite, human blood index, feeding and resting behaviour.

    Measured: Average for months Sept, Oct, Nov for years 2011, 2012, 2013

  3. Frequency of insecticide resistance associated genotypes (kdr) in anopheles arabiensis

    Molecular analysis of mosquito specimens caught in subset of clusters by pyrethrum spray collection.

    Measured: Yearly average 2011, 2012, 2013, 2014

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Oct 2012 (estimated)
  2. Study startApr 2011
  3. Primary completionOct 2014 (estimated)
  4. Study completionOct 2014 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
28,000 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01713517
Sponsor's protocol ID
WHO_IR_SUDAN
Status last verified
Oct 2012
First submitted
22 Oct 2012
Last updated
26 Oct 2012
Results posted
No
Data monitoring committee
Yes

Publications

  • Kafy HT, Ismail BA, Mnzava AP, Lines J, Abdin MSE, Eltaher JS, Banaga AO, West P, Bradley J, Cook J, Thomas B, Subramaniam K, Hemingway J, Knox TB, Malik EM, Yukich JO, Donnelly MJ, Kleinschmidt I. Impact of insecticide resistance in Anopheles arabiensis on malaria incidence and prevalence in Sudan and the costs of mitigation. Proc Natl Acad Sci U S A. 2017 Dec 26;114(52):E11267-E11275. doi: 10.1073/pnas.1713814114. Epub 2017 Dec 11.

    PubMed 29229808

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing Indoor residual insecticide spraying (IRS) and Long Lasting Insecticidal Nets (LLIN) in people with Malaria, Falciparum, run by London School of Hygiene and Tropical Medicine at 3 sites in Sudan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 26 Oct 2012. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in Sudan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Hmooda T Kafy, MSc (London) (+249 123 399 994, hmoodak@yahoo.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Malaria Incidence (time frame: 3 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01713517, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Oct 2012.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in